Atlas Trials

PSUNRISE - Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept

Clinical trial NCT00527072 · COMPLETED

Trial details

NCT number
NCT00527072
Sponsor
Centocor Ortho Biotech Services, L.L.C.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Psoriasis
Start date
2007-07-01
Primary completion
2009-05-01
Enrollment
217

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.